Bisphosphonates: do we know their role in adjuvant breast cancer treatment?

Barginear, Myra F; Van Poznak, Catherine

Barginear, Myra F; Van Poznak, Catherine.

Affiliation

Barginear MF; Department of Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, New York, USA.

Oncology (Williston Park) ; 24(6): 475, 478, 480, 2010 May.

Article in En | MEDLINE | ID: mdl-20568588

Subject(s)

Bone Density Conservation Agents/therapeutic use; Breast Neoplasms/drug therapy; Diphosphonates/therapeutic use; Osteoporosis/prevention & control; Bone Density; Breast Neoplasms/complications; Clinical Trials as Topic; Female; Humans

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Breast Neoplasms / Diphosphonates / Bone Density Conservation Agents Limits: Female / Humans Language: En Journal: Oncology (Williston Park) Journal subject: NEOPLASIAS Year: 2010 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google